期刊文献+

病毒性肝炎患者血清胰岛素样生长因子结合蛋白3浓度的测定及对肝功能的评价

Measurement of serum level of insulin-like growth factor binding protein-3 in patients with viral hepatitis and its assessment on liver function
下载PDF
导出
摘要 探讨各型病毒性肝炎患者血清胰岛素样生长因子结合蛋白-3(Insulin-like growth factor binding protein3,IGFBP-3)浓度的变化及其对肝功能的评价。经ELISA法检测,10例正常对照、10例急性肝炎、10例慢性肝炎中度、11例慢性肝炎重度、12例慢性重型肝炎及11例肝硬化患者血清中IGFBP-3的浓度分别为4891.63±1482.91、4243.88±1086.02、3361.38±584.11、3021.63±946.48、1951.13±791.96及1146.93±443.15ng/ml。除急性肝炎组外,肝炎患者血清IGFBP-3浓度均显著低于正常对照组;血清IGFBP-3浓度与血清白蛋白、前白蛋白呈正相关,而与凝血酶原时间、总胆红素及直接胆红素呈负相关,与AST、ALT无显著相关性。血清IGFBP-3浓度能较好地反映各型病毒性肝炎患者的肝功能损害程度。 To investigate its level in patients with different kinds of viral hepatitis and its assessment on liver function, the serum level of insulin- like growth factor binding protein- 3 (IGFBP- 3 )was measured by ELISA in 10 heahhy controls. 10 eases with acute hepatitis. 10 eases with moderate degree chronic hepatitis.11 eases with severe degree chronic hepatitis. 12 cases of severe hepatitis and 11 cases of cirrhosis, whose results were 4891.63 ± 1482.91,4243.88 ± 1086.02,3361.38 ± 584.11,3021.63 ± 946.48,1951.13 ± 791.96 and 1146.93 ± 443.15 ng/ml, respectively. Compared with healthy controls, sermn IGFBP - 3 levels in patients with viral hepatitis were much lower exeept acute hepatitis. The serum IGFBP - 3 level decreases as the damage of liver function aggravates. There was significant positive correlation between serum IGFBP- 3 and serum albumin, prealbumin, while negative with serum prothrombin time, total serum bilimbin and direct serum bilirubin. No signifieant eorrelation was found be tween serum IGFBP - 3 and ALT, AST. Sermn IGFBP - 3 level is a good marker for the evaluation of liver function.
出处 《临床肝胆病杂志》 CAS 2006年第1期24-26,共3页 Journal of Clinical Hepatology
基金 长沙市科技局课题资助(K041118-32)
关键词 病毒性肝炎 胰岛素样生长因子结合蛋白-3 肝功能 viral hepatitis insulin - like growth factor binding protein - 3 liver function
  • 相关文献

参考文献11

  • 1Monzavi R,Cohen P.IGFs and IGFBPs:role in health and disease[ J].Best Pract Res Clin Endocrinol Metab,2002,16(3):433-447. 被引量:1
  • 2吴云林,叶静,张曙,钟捷,奚容平,郑志存,杨列,林敏,屈仁义.肝硬化患者血清胰岛素样生长因子及其结合蛋白测定与肝功能状况的关系[J].中华消化杂志,2002,22(10):601-604. 被引量:16
  • 3Sidlova K,Pechova M,Akotaska K,et al.Insulin-like growth factor binding protein-3 in patients with liver cirrhosis [ J ].Physiol Res,2002,51(6):587-90. 被引量:1
  • 4Shaarawy M,Fikry MA,Massoud BA,et al.Insulin-like growth factor binding protein-3:a novel biomarker for the assessment of the synthetic capacity of hepatocytes in liver cirrhosis [ J ].J Clin Endocrinol Metab,1998,83(9):3316-9. 被引量:1
  • 5中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14010
  • 6Weber MM,Auernhammer CJ,Lee PD,et al.Insulin-like growth factors and insulin-like growth factor binding proteins in adult patients with severe liver disease before and after orthotopic liver transplantation [ J].Horm Res,2002,57(3-4):105-12. 被引量:1
  • 7Sehalch DS,Kalayoglu M,Pirsch JD,et al.Serum insulin-like growth factors and their binding proteins in patients with hepatic failure and after liver transplantation[ J].Metabolism,1998,47(2):200-6. 被引量:1
  • 8Ottesen LH,Bendtsen F,Flyvbjerg A.The insulin-like growth factor binding protein 3 ternary complex is reduced in cirrhosis [ J].Liver,2001,21 (5):350-6. 被引量:1
  • 9Donaghy A J,Delhanty PJ,Ho KK,et al.Regulation of the growth hormone receptor/binding protein,insulin-like growth factor ternary complex system in human cirrhosis[J].J Hepatol,2002,36(6):751-8. 被引量:1
  • 10Wallace JD,Abbott-Johnson WJ,Crawford DH,et al.GH treatment in adults with chronic liver disease:a randomized,double-blind,placebo-controlled,cross-over study [ J].J Clin Endocrinol Metab,2002,87(6):2751-9. 被引量:1

二级参考文献15

  • 1Boisclaair Y R,J Biol Chem,2000年,11卷,3841页 被引量:1
  • 2Shen X Y,J Clin Endoc Metab,1998年,83卷,2352页 被引量:1
  • 3Moller S, Juul A, Becker U, et al. The acid-labile subunit of theternary insulin-like growth factor complex in cirrhosis: relation toliver dysfunction. J Hepatol, 2000, 32:441-446. 被引量:1
  • 4Assy N, Hochberg Z, Amit T, et al. Growth hormone-stimulatedinsulin-like growth factor (IGF)-Ⅰ and IGF-binding protein-3 inliver cirrhosis. J Hepatol, 1997, 27:796-802. 被引量:1
  • 5Donaghy A, Ross R, Gimson A, et al. Growth hormone, insulinlike growth factor- Ⅰ , and insulin-like growth factor binding 1 and3 in chronic liver disease. Hepatology, 1995, 21:680-688. 被引量:1
  • 6NikolicJA, Todorovic V, Bozic M, et al. Serum insulin-likegrowth factor ( IGF)- Ⅱ is more closely associated with liver dysfunction that is ( IGF)- Ⅰ in patients with cirrhosis. Clin ChimActa, 2000, 294: 169-177. 被引量:1
  • 7Caregaro L, Alberino F, Amodio P, et al. Nutritional and prognostic significance of insulin-like growth factor 1 in patients withliver cirrhosis. Nutrition, 1997, 13:185-190. 被引量:1
  • 8Petersen KF, Jacob R, West AB, et al. Effects of insulin-likegrowth factor Ⅰ on glucose metabolism in rats with liver cirrhosis.Am J Physiol, 1997, 273:e1189-e1193. 被引量:1
  • 9Inaba T, Saito H, Inoue T, et al. Growth hormone/insulin-likegrowth factor 1 axis alterations contribute to disturbed proteinmetabolism in cirrhosis patients after hepatectomy. J Hepatol,1999, 31:271-276. 被引量:1
  • 10Scharf JG, Schmitz F, Frystyk J, et al. Insulin-like growth factorI serum concentrations and patterns of insulin-like growth factorbinding proteins in patients with chronic liver disease. J Hepatol,1996, 25: 689-699. 被引量:1

共引文献14032

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部